{"corpus_id":271881152,"paper_sha":"4dd57d41274332ec9a01343b03732d4601f40e7f","doi":"10.1038/s41531-024-00752-9","arxiv_id":null,"pmid":39147844,"pmcid":"11327306","mag_id":null,"dblp_id":null,"acl_id":null,"title":"Loss-of-function variants in ITSN1 confer high risk of Parkinson’s disease","year":2024,"publication_date":"2024-08-15","venue":"npj Parkinson's Disease","journal":{"name":"NPJ Parkinson's Disease","pages":null,"volume":"10"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine"],"reference_count":33,"citation_count":10,"influential_citation_count":1,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Parkinson’s disease (PD) is a debilitating neurodegenerative disorder and its rising global incidence highlights the need for the identification of modifiable risk factors. In a gene-based burden test of rare variants (8647 PD cases and 777,693 controls) we discovered a novel association between loss-of-function variants in ITSN1 and PD. This association was further supported with burden data from the Neurodegenerative Disease Knowledge Portal and the Accelerating Medicines Partnership Parkinson’s Disease Knowledge Platform. Our findings show that Rho GTPases and disruptions in synaptic vesicle transport may be involved in the pathogenesis of PD, pointing to the possibility of novel therapeutic approaches.","claims":[{"public_id":"cl_4ce443b563c0a6108da088010a2d306a","status":"active","text":"A gene-based burden test in 8,647 Parkinson’s disease cases and 777,693 controls identified a novel ITSN1 association.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_4ce443b563c0a6108da088010a2d306a"},{"public_id":"cl_ef4f2d35f6396bbecdbd8463faf3180d","status":"active","text":"Burden data from the Neurodegenerative Disease Knowledge Portal and the Accelerating Medicines Partnership Parkinson’s Disease Knowledge Platform supported the ITSN1 association.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_ef4f2d35f6396bbecdbd8463faf3180d"},{"public_id":"cl_f695bedf01cef723dc3154a88ec5b223","status":"active","text":"Rare loss-of-function variants in ITSN1 are associated with high risk of Parkinson’s disease.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_f695bedf01cef723dc3154a88ec5b223"},{"public_id":"cl_f2a30480c282af500d767c5b349c8c24","status":"active","text":"Rho GTPases and synaptic vesicle transport disruptions may be involved in Parkinson’s disease pathogenesis.","confidence":0.86,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_f2a30480c282af500d767c5b349c8c24"}],"concepts":[{"public_id":"co_04c299e7f8c477adc908a68d8a77ed5f","status":"active","name":"synaptic vesicle transport","description":"The cellular process by which synaptic vesicles are moved and recycled at nerve terminals.","types":["cellular process"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_04c299e7f8c477adc908a68d8a77ed5f"},{"public_id":"co_1632b6f624000089171363b5c3241d37","status":"active","name":"Accelerating Medicines Partnership Parkinson’s Disease Knowledge Platform","description":"A Parkinson’s disease knowledge platform used to support genetic burden findings.","types":["database"],"aliases":["AMP PD Knowledge Platform"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_1632b6f624000089171363b5c3241d37"},{"public_id":"co_1f4aa53c2d14c8a0f5f517df74c98c7a","status":"active","name":"777,693 controls","description":"The number of control individuals included in the burden analysis.","types":["study cohort"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_1f4aa53c2d14c8a0f5f517df74c98c7a"},{"public_id":"co_5f518f5c5a7d9c1a8f5b599d7f26177f","status":"active","name":"gene-based burden test","description":"A statistical test that aggregates rare variants within a gene to assess association with disease.","types":["statistical method"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5f518f5c5a7d9c1a8f5b599d7f26177f"},{"public_id":"co_c9c19548445e222bb6723571f819166c","status":"active","name":"loss-of-function variants in ITSN1","description":"Rare genetic variants in the ITSN1 gene that reduce or abolish gene function.","types":["genetic variant"],"aliases":["ITSN1 loss-of-function variants","LOF variants in ITSN1"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c9c19548445e222bb6723571f819166c"},{"public_id":"co_d15cd21f16b3a95a5003b13f0a3a90e6","status":"active","name":"Rho GTPases","description":"A family of signaling proteins involved in regulating cytoskeletal and vesicular processes.","types":["protein family"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d15cd21f16b3a95a5003b13f0a3a90e6"},{"public_id":"co_f09d3306fab69bc261b97995a765c8ad","status":"active","name":"Neurodegenerative Disease Knowledge Portal","description":"A knowledge portal that provides neurodegenerative disease genetic and association data.","types":["database"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f09d3306fab69bc261b97995a765c8ad"},{"public_id":"co_f3ed483e6e61fb4ef5ad2b8f5754e829","status":"active","name":"Parkinson’s disease","description":"A neurodegenerative disorder characterized by progressive motor and non-motor symptoms.","types":["disease"],"aliases":["PD"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f3ed483e6e61fb4ef5ad2b8f5754e829"},{"public_id":"co_fa5bcb10ab84215894cc03a56aa6fbe2","status":"active","name":"8,647 Parkinson’s disease cases","description":"The number of individuals with Parkinson’s disease included in the burden analysis.","types":["study cohort"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fa5bcb10ab84215894cc03a56aa6fbe2"}],"external_ids":{"DOI":"10.1038/s41531-024-00752-9","ArXiv":null,"PubMed":39147844,"PubMedCentral":"11327306","MAG":null,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/271881152","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":637562,"paper_uid":"cb1cf1be-cac4-4b19-af0b-ef25791d076e","canonical_identity":{"paper_id":637562,"paper_uid":"cb1cf1be-cac4-4b19-af0b-ef25791d076e","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/271881152"}